166 related articles for article (PubMed ID: 32649963)
1. A comparative study of extracellular enzymes from chromoblastomycosis agents reveals the potential association of phospholipase with the severity of the lesions.
Montoya AM; Montesino CA; Carrión-Álvarez D; González GM; Rojas OC
Microb Pathog; 2020 Oct; 147():104367. PubMed ID: 32649963
[TBL] [Abstract][Full Text] [Related]
2. Secretion of five extracellular enzymes by strains of chromoblastomycosis agents.
Souza TF; Scroferneker ML; Costa JM; Carissimi M; Corbellini VA
Rev Inst Med Trop Sao Paulo; 2008; 50(5):269-72. PubMed ID: 18949343
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic and molecular identification of Fonsecaea pedrosoi strains isolated from chromoblastomycosis patients in Mexico and Venezuela.
Carolina Rojas O; León-Cachón RB; Pérez-Maya AA; Aguirre-Garza M; Moreno-Treviño MG; González GM
Mycoses; 2015 May; 58(5):267-72. PubMed ID: 25728464
[TBL] [Abstract][Full Text] [Related]
4. Chromoblastomycosis in the Amazon region, Brazil, caused by Fonsecaea pedrosoi, Fonsecaea nubica, and Rhinocladiella similis: Clinicopathology, susceptibility, and molecular identification.
de Andrade TS; de Almeida AMZ; Basano SA; Takagi EH; Szeszs MW; Melhem MSC; Albuquerque M; Camargo JSAA; Gambale W; Camargo LMA
Med Mycol; 2020 Feb; 58(2):172-180. PubMed ID: 31329924
[TBL] [Abstract][Full Text] [Related]
5. Phospholipase and esterase production by clinical strains of Fonsecaea pedrosoi and their interactions with epithelial cells.
Palmeira VF; Kneipp LF; Alviano CS; dos Santos AL
Mycopathologia; 2010 Jul; 170(1):31-7. PubMed ID: 20195904
[TBL] [Abstract][Full Text] [Related]
6. Endemic Chromoblastomycosis Caused Predominantly by Fonsecaea nubica, Madagascar
Rasamoelina T; Maubon D; Andrianarison M; Ranaivo I; Sendrasoa F; Rakotozandrindrainy N; Rakotomalala FA; Bailly S; Rakotonirina B; Andriantsimahavandy A; Rabenja FR; Andrianarivelo MR; Cornet M; Ramarozatovo LS
Emerg Infect Dis; 2020 Jun; 26(6):1201-1211. PubMed ID: 32441639
[TBL] [Abstract][Full Text] [Related]
7. Extensive chromoblastomycosis caused by Fonsecaea pedrosoi successfully treated with a combination of amphotericin B and itraconazole.
Paniz-Mondolfi AE; Colella MT; Negrín DC; Aranzazu N; Oliver M; Reyes-Jaimes O; Pérez-Alvarez AM
Med Mycol; 2008 Mar; 46(2):179-84. PubMed ID: 18324498
[TBL] [Abstract][Full Text] [Related]
8. Chromoblastomycosis: an overview of clinical manifestations, diagnosis and treatment.
Queiroz-Telles F; Esterre P; Perez-Blanco M; Vitale RG; Salgado CG; Bonifaz A
Med Mycol; 2009 Feb; 47(1):3-15. PubMed ID: 19085206
[TBL] [Abstract][Full Text] [Related]
9. A screening of the MMV Pathogen Box® reveals new potential antifungal drugs against the etiologic agents of chromoblastomycosis.
Coelho RA; Joffe LS; Alves GM; Figueiredo-Carvalho MHG; Brito-Santos F; Amaral ACF; Rodrigues ML; Almeida-Paes R
PLoS One; 2020; 15(5):e0229630. PubMed ID: 32401759
[TBL] [Abstract][Full Text] [Related]
10. Combination of Amphotericin B and Terbinafine against Melanized Fungi Associated with Chromoblastomycosis.
Deng S; Lei W; de Hoog GS; Yang L; Vitale RG; Rafati H; Seyedmousavi M; Tolooe A; van der Lee H; Liao W; Verweij PE; Seyedmousavi S
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29581111
[TBL] [Abstract][Full Text] [Related]
11. Chromoblastomycosis in sub-tropical regions of India.
Sharma A; Hazarika NK; Gupta D
Mycopathologia; 2010 May; 169(5):381-6. PubMed ID: 20094803
[TBL] [Abstract][Full Text] [Related]
12. In vitro photodynamic therapy against Foncecaea pedrosoi and Cladophialophora carrionii.
Lyon JP; Moreira LM; de Carvalho VS; dos Santos FV; de Lima CJ; de Resende MA
Mycoses; 2013 Mar; 56(2):157-61. PubMed ID: 22816425
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility of sequential Fonsecaea pedrosoi isolates from chromoblastomycosis patients to antifungal agents.
Andrade TS; Castro LG; Nunes RS; Gimenes VM; Cury AE
Mycoses; 2004 Jun; 47(5-6):216-21. PubMed ID: 15189187
[TBL] [Abstract][Full Text] [Related]
14. Chromoblastomycosis: an etiological, epidemiological, clinical, diagnostic, and treatment update.
Brito AC; Bittencourt MJS
An Bras Dermatol; 2018; 93(4):495-506. PubMed ID: 30066754
[TBL] [Abstract][Full Text] [Related]
15. Case Report: A Case of Chromoblastomycosis Caused by Fonsecaea pedrosoi in Vietnam.
Le TA; Nguyen KL; Pham MH; Vi TT; Do NA
Mycopathologia; 2019 Feb; 184(1):115-119. PubMed ID: 29974323
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of skin test for chromoblastomycosis using antigens prepared from culture filtrates of Fonsecaea pedrosoi, Phialophora verrucosa, Wangiella dermatitidis and Exophiala jeanselmei.
Iwatsu T; Miyaji M; Taguchi H; Okamoto S
Mycopathologia; 1982 Jan; 77(1):59-64. PubMed ID: 7070478
[TBL] [Abstract][Full Text] [Related]
17. Molecular identification of chromoblastomycosis clinical isolates in Guangdong.
Fransisca C; He Y; Chen Z; Liu H; Xi L
Med Mycol; 2017 Nov; 55(8):851-858. PubMed ID: 28053146
[TBL] [Abstract][Full Text] [Related]
18. Chromoblastomycosis--a clinical and mycological study of 71 cases from Sri Lanka.
Attapattu MC
Mycopathologia; 1997; 137(3):145-51. PubMed ID: 9368408
[TBL] [Abstract][Full Text] [Related]
19. Itraconazole in the treatment of chromoblastomycosis due to Fonsecaea pedrosoi.
Queiroz-Telles F; Purim KS; Fillus JN; Bordignon GF; Lameira RP; Van Cutsem J; Cauwenbergh G
Int J Dermatol; 1992 Nov; 31(11):805-12. PubMed ID: 1330949
[TBL] [Abstract][Full Text] [Related]
20. Chromoblastomycosis by Cladophialophora carrionii associated with squamous cell carcinoma and review of published reports.
Rojas OC; González GM; Moreno-Treviño M; Salas-Alanis J
Mycopathologia; 2015 Feb; 179(1-2):153-7. PubMed ID: 25344197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
